title: The effect of myocardial preservation technique on supraventricular tachycardia following aortic valve replacement.
abstract: We studied 100 patients who underwent an isolated aortic valve replacement (AVR) between 1974 and 1991. The patients were divided into the following two groups and compared: group A, which consisted of 40 patients operated on before 1978 who underwent continuous left coronary perfusion with blood; and group B, which consisted of 60 patients operated on after 1979 in whom St. Thomas solution was used in combination with topical cardiac cooling. Moreover, we divided the group B patients into two subgroups: group B1, who underwent AVR before 1986 during which we administered St. Thomas solution with ice slush every 30 min; and group B2, who had AVR after 1986 in which we used St. Thomas solution with a cold saline (4 degrees C) solution and treated with a small amount of slushed ice very 15 min. The incidence of supraventricular tachycardias was 15% in group A, 50% in group B1, and 15% in group B2. The severity of preoperative New York Heart Association (NYHA) functional class, the type of valve lesions, cardiothoracic ratio, left ventricular function, aortic clamp time, bypass time, and use of drugs did not correlate with the incidence of supraventricular tachycardias in either group A or B. In group B2 patients, we paid a lot of attention to cooling the right atrium as well as the left ventricle by immersing the whole heart using a 4 degrees C saline solution, which led to a remarkable reduction of the incidence of supraventricular tachycardia. This fact indicates that right atrial preservation is one of the most important factors for reducing the incidence of supraventricular tachycardia.
authors.affiliation: Department of Cardiovascular Surgery, Okayama University Medical School, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Shigenobu
authors.forename: S
authors.initials: S
authors.lastname: Teramoto
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001639:Bicarbonates / Q000008:administration & dosage; D001769:Blood; D002122:Calcium Chloride / Q000008:administration & dosage; D005260:Female; D006324:Heart Arrest, Induced / Q000009:adverse effects / Q000379:methods*; D006350:Heart Valve Prosthesis; D006801:Humans; D007036:Hypothermia, Induced; D008274:Magnesium / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D015425:Myocardial Reperfusion; D011183:Postoperative Complications / Q000517:prevention & control; D011189:Potassium Chloride / Q000008:administration & dosage; D012965:Sodium Chloride / Q000008:administration & dosage; D013617:Tachycardia, Supraventricular / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D001639:Bicarbonates; C041711:St. Thomas' Hospital cardioplegic solution; D012965:Sodium Chloride; D011189:Potassium Chloride; D008274:Magnesium; D002122:Calcium Chloride